Evidence map›Paper›PMID 28395734›Full record

ArticleeLife2017

O-GlcNAc on NOTCH1 EGF repeats regulates ligand-induced Notch signaling and vascular development in mammals.

Shogo Sawaguchi, Shweta Varshney, Mitsutaka Ogawa, Yuta Sakaidani, Hirokazu Yagi, Kyosuke Takeshita, Toyoaki Murohara, Koichi Kato, Subha Sundaram, Pamela Stanley and 1 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 94 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Biomolecular NMR assignments · 2023
    Article
  16. Review
  17. Article
  18. Article
  19. Cancers · 2022
    Review
  20. Optogenetic control of NOTCH1 signaling.Cell communication and signaling : CCS · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Shogo SawaguchiDepartment of Molecular Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Shweta VarshneyDepartment of Cell Biology, Albert Einstein College of Medicine, New York, United States.
Mitsutaka OgawaDepartment of Molecular Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yuta SakaidaniDepartment of Molecular Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hirokazu YagiGraduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan.
Kyosuke TakeshitaDepartment of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Toyoaki MuroharaDepartment of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Koichi KatoGraduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan.
Subha SundaramDepartment of Cell Biology, Albert Einstein College of Medicine, New York, United States.
Pamela StanleyDepartment of Cell Biology, Albert Einstein College of Medicine, New York, United States.ORCID 0000-0001-5704-3747
Tetsuya OkajimaDepartment of Molecular Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID 0000-0002-3677-648X
Nagoya University · JPAlbert Einstein College of Medicine · USNagoya City University · JPNational Institutes of Natural Sciences · JP

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
Special Animal CoreP30DK041296 · NIDDK · YESHIVA UNIVERSITY · PI WOLKOFF, ALLAN W · 1989 to 2018
$22.9M
Roles of Glycoslyation in Notch SignalingR01CA095022 · NCI · YESHIVA UNIVERSITY · PI STANLEY, PAMELA M · 2002 to 2011
$4.1M
Roles of Glycoslyation in Notch SignalingR01GM106417 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STANLEY, PAMELA M · 2013 to 2021
$3.8M
High-speed/resolution whole slide scanner supported by two core facilitiesS10OD019961 · OD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI CONDEELIS, JOHN S · 2015 to 2015
$326k
NCI NIH HHS P30 CA013330NIDDK NIH HHS P30 DK041296NIGMS NIH HHS R01 GM106417NIH HHS S10 OD019961
6 · The paper itself

Abstract

The glycosyltransferase EOGT transfers O-GlcNAc to a consensus site in epidermal growth factor-like (EGF) repeats of a limited number of secreted and membrane proteins, including Notch receptors. In EOGT-deficient cells, the binding of DLL1 and DLL4, but not JAG1, canonical Notch ligands was reduced, and ligand-induced Notch signaling was impaired. Mutagenesis of O-GlcNAc sites on NOTCH1 also resulted in decreased binding of DLL4. EOGT functions were investigated in retinal angiogenesis that depends on Notch signaling. Global or endothelial cell-specific deletion of

Indexed as

GlycosylationNeovascularization, PhysiologicSignal TransductionAcetylglucosamineAnimalsCell LineCricetinaeEndothelial CellsHumansMiceN-AcetylglucosaminyltransferasesReceptor, Notch1RetinaAcetylglucosamineEOGT protein, humanN-AcetylglucosaminyltransferasesReceptor, Notch1biochemistrydevelopmental biologyDLL4EOGTmouseNotch signalingO-GlcNAcretinal angiogenesisstem cells

Identifiers

PMID28395734
PMCPMC5388531
OpenAlexW2607329920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.